Subburaj Ilangumaran

13PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 22, 2026
NLRC5 expression within tumor cells is critical to activate adaptive and innate antitumor immune responses.

|Aug 18, 2025
Essential Role of NLRC5 in Cancer Immune Surveillance and Cancer Immunoediting.

Akhil Shukla, Anny Armas Cayarga, Jean-François Lucier

|Jan 23, 2024
The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma.

Akhil Shukla, Md Gulam Musawwir Khan, Anny Armas Cayarga

|Apr 28, 2023
NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity.

Madanraj Appiya Santharam, Akhil Shukla, Dominique Levesque

|Feb 11, 2023
SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation.

Md Gulam Musawwir Khan, Nadia Boufaied, Mehdi Yeganeh

|Feb 11, 2023
IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation.

Madhuparna Nandi, Amit Ghosh, Sara Ali Akbari

Pageof 3

Frequent Collaborators

3 joint publications

Sheela Ramanathan

2 joint publications

Md Gulam Musawwir Khan

2 joint publications

Thomas A Kufer

1 joint publications

Matthew D Smith